Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Thymosin Alpha-1 (adaptive immune modulation), KPV (anti-inflammatory alpha-MSH fragment), and LL-37 (direct antimicrobial cathelicidin) target three layers of immune defense — T-cell maturation, inflammatory regulation, and pathogen killing.
Thymosin Alpha-1 is a 28-amino acid peptide naturally produced by the thymus gland that plays a critical role in immune system regulation. It is approved in over 35 countries for treating hepatitis B and C and as an immune adjuvant, and is studied for cancer immunotherapy.
Role: Adaptive immune modulator. Thymic peptide that drives T-cell maturation, dendritic cell activation, and cytokine balance. FDA orphan drug for hepatitis B (Zadaxin).
KPV is a naturally occurring anti-inflammatory tripeptide derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). It is studied for its potent anti-inflammatory effects in the gut and skin without the pigmentation effects of full alpha-MSH.
Role: Anti-inflammatory tripeptide. Alpha-MSH(11-13) fragment that suppresses NF-kB signaling and proinflammatory cytokines in mucosal and systemic inflammation models.
LL-37 is the only human cathelicidin antimicrobial peptide, produced by immune cells, epithelial cells, and skin. It plays a critical role in the innate immune defense against bacteria, viruses, and fungi, and is studied for chronic infections and wound healing.
Role: Antimicrobial cathelicidin. Human host defense peptide with direct bactericidal, antiviral, and immunomodulatory activity via membrane disruption.
Use the protocol builder to set doses, frequency, and cycle length. Track your progress with blood work integration.
Start ProtocolFor research purposes only. Not medical advice, diagnosis, or treatment. Consult a licensed provider before making any decisions based on this information.
Anti-Aging & Longevity Stack
Telomeres, mitochondria, and matrix remodeling